IDiyas

For the Inventor, By the Inventor

Shizuoka, Japan

Haruki Takai

USPTO Granted Patents = 19

Average Co-Inventor Count = 7.1

ph-index = 7

Forward Citations = 100(Granted Patents)


Location History:

  • Kawasaki, JP (1982 - 1983)
  • Shizuoka-ken, JP (1997)
  • Sunto-gun, JP (1997)
  • Shizuoka, JP (1987 - 1999)
  • Yokohama, JP (1997 - 2001)

Company Filing History:

goldMedal18 out of 730 
 
Kyowa Hakko Kogyo Co., Ltd.
 patents
silverMedal1 out of 2 
 
Kyowa Hakko Kogyo K.k.
 patents

Years Active: 1982-2001

Loading Chart...
19 patents (USPTO):Explore Patents
1. 6211227 - Tricyclic compounds (2001-04-03),
2. 5948784 - Quinazoline derivatives (1999-09-07),
3. 5891902 - Indole derivatives (1999-04-06),
4. 5726325 - Tricyclic compounds (1998-03-10),
5. 5698560 - Imidazoquinazoline derivatives (1997-12-16),
6. 5661147 - Imidazoquinazoline derivatives (1997-08-26),
7. 5658917 - Isoquinolines having adenosine uptake inhibitor activity (1997-08-19),
8. 5648353 - Quinazolines and phthalazines having adenosine uptake inhibitor activity (1997-07-15),
9. 5624926 - Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors (1997-04-29),
10. 5605900 - Benzotriazines having adenosine uptake inhibitor activity (1997-02-25),
11. 5523464 - Benzenesulfonamide derivatives (1996-06-04),
12. 5413997 - Triphenylmethane derivatives (1995-05-09),
13. 5374634 - Pyridine derivatives (1994-12-20),
14. 5112867 - Triphenylmethane derivatives (1992-05-12),
15. 5063227 - Quinazoline-substituted pyridazinone derivatives having cardiotonic (1991-11-05),

Title: The Innovative Contributions of Haruki Takai in Pharmaceutical Patents

Introduction

Haruki Takai is an esteemed inventor based in Shizuoka, Japan, known for his significant contributions to the field of pharmaceutical innovation. With a total of 19 patents to his name, Takai has been dedicated to developing novel compounds that address critical health issues.

Latest Patents

Among his most recent patents, Takai has developed innovative tricyclic compounds aimed at treating pollakiuria and urinary incontinence. These compounds are represented by a general formula (I) and demonstrate promising therapeutic potential. Additionally, he has disclosed quinazoline derivatives characterized by a complex chemical structure. These derivatives, represented by formula (I), showcase adenosine uptake inhibitory activity, making them beneficial for the protection of myocardium and for preventing or treating renal diseases such as nephritis and diabetic nephropathy.

Career Highlights

Throughout his career, Haruki Takai has worked with notable companies, including Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kogyo K.K. His role in these organizations has facilitated the research and development of groundbreaking pharmaceutical products, further solidifying his reputation as an influential inventor in the industry.

Collaborations

Takai has collaborated with esteemed colleagues in the field, including Daisuke Machii and Akira Karasawa. Their collective expertise and teamwork have been instrumental in advancing research initiatives that align with Takai's innovative pursuits.

Conclusion

Haruki Takai's contributions to pharmaceutical patents underscore his dedication to improving health outcomes through innovation. His work on tricyclic compounds and quinazoline derivatives highlights the impact of his inventions on medical science, positioning him as a prominent figure in the realm of inventors. As the field continues to evolve, Takai's patents may pave the way for new treatments that benefit countless patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…